Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.bbrc.2021.06.001

http://scihub22266oqcxt.onion/10.1016/j.bbrc.2021.06.001
suck pdf from google scholar
34116356!8179121!34116356
unlimited free pdf from europmc34116356    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid34116356      Biochem+Biophys+Res+Commun 2021 ; 566 (ä): 45-52
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Analysis of the molecular mechanism of SARS-CoV-2 antibodies #MMPMID34116356
  • Jin D; Wei J; Sun J
  • Biochem Biophys Res Commun 2021[Aug]; 566 (ä): 45-52 PMID34116356show ga
  • A newly-emergent beta-coronavirus, SARS-CoV-2, rapidly has become a pandemic since 2020. It is a serious respiratory disease and caused more than 100 million of deaths in the world. WHO named it COVIA-19 and there is no effective targeted drug for it. The main treatment strategies include chemical medicine, traditional Chinese medicine (TCM) and biologics. Due to SARS-CoV-2 uses the spike proteins (S proteins) on its envelope to infect human cells, monoclonal antibodies that neutralize the S protein have become one of the hot research areas in the current research and treatment of SARS-CoV-2. In this study, we reviewed the antibodies that have been reported to have neutralizing activity against the SARS-CoV-2 infection. According to their different binding epitope regions in RBD or NTD, they are classified, and the mechanism of the representative antibodies in each category is discussed in depth, which provides potential foundation for future antibody and vaccine therapy and the development of antibody cocktails against SARS-CoV-2 mutants.
  • |Angiotensin-Converting Enzyme 2/chemistry[MESH]
  • |Antibodies, Monoclonal/chemistry/immunology/therapeutic use[MESH]
  • |Antibodies, Neutralizing/chemistry/*immunology/therapeutic use[MESH]
  • |Antibodies, Viral/chemistry/*immunology/therapeutic use[MESH]
  • |COVID-19 Vaccines/immunology[MESH]
  • |COVID-19/*immunology/therapy/*virology[MESH]
  • |Epitopes/immunology[MESH]
  • |Humans[MESH]
  • |Models, Molecular[MESH]
  • |Neutralization Tests[MESH]
  • |Pandemics[MESH]
  • |Protein Interaction Domains and Motifs[MESH]
  • |Receptors, Virus/chemistry[MESH]
  • |SARS-CoV-2/genetics/*immunology[MESH]
  • |Single-Domain Antibodies/immunology[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box